---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-016039"
form_type: "8-K"
ticker: "AKTX"
cik: "0001541157"
company_name: "Akari Therapeutics Plc"
filed_at: "2025-09-29T23:59:59+00:00"
generated_at: "2026-05-17T05:23:58.716335+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Akari closes final tranche of August 2025 notes offering for $250K purchase price

## Summary
- Aggregate purchase price of $3 million for notes with 20% original issuance discount.
- Total principal amount issued approximately $3.8 million across all tranches.
- Final tranche: $312,500 principal issued for $250,000 purchase price.
- Notes are unsecured promissory notes issued under note purchase agreements dated August 1, 2025.

## SEC filing metadata
- accession: 0001493152-25-016039
- form_type: 8-K
- ticker: AKTX
- cik: 0001541157
- company_name: Akari Therapeutics Plc
- filed_at: 2025-09-29T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1541157/000149315225016039/0001493152-25-016039-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1541157/000149315225016039/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-016039
- JSON: https://secwatch.observer/filing/0001493152-25-016039.json
- Plain text: https://secwatch.observer/filing/0001493152-25-016039.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.